Patents by Inventor Ulrik Lytt Rahbek

Ulrik Lytt Rahbek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
    Patent number: 11622996
    Abstract: The invention relates to pharmaceutical compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Grant
    Filed: May 6, 2019
    Date of Patent: April 11, 2023
    Assignee: Novo Nordisk A/S
    Inventors: Simon Bjerregaard, Ulrik Lytt Rahbek, Philip Jonas Sassene, Jorrit Jeroen Water, Andreas Vegge
  • Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
    Publication number: 20230087952
    Abstract: The invention relates to pharmaceutical compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Application
    Filed: November 16, 2022
    Publication date: March 23, 2023
    Inventors: Simon Bjerregaard, Ulrik Lytt Rahbek, Philip Jonas Sassene, Jorrit Jeroen Water, Andreas Vegge
  • SOLID COMPOSITIONS COMPRISING A PCSK9 INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
    Publication number: 20230000949
    Abstract: The invention relates to pharmaceutical compositions comprising a PCSK9 inhibitor, such as an EGF(A) peptide, and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Application
    Filed: November 6, 2020
    Publication date: January 5, 2023
    Inventors: Simon Bjerregaard, Ulrik Lytt Rahbek, Philip Jonas Sassene, Jorrit Jeroen Water, Andreas Vegge, Kaisa Naelapaeae
  • SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, AN SGLT2 INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
    Publication number: 20220395559
    Abstract: The invention relates to pharmaceutical compositions comprising a GLP-1 agonist, an SLGT2 inhibitor, a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid, and a hydrotrope. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Application
    Filed: November 6, 2020
    Publication date: December 15, 2022
    Inventors: Kaisa Naelapaeae, Simon Bjerregaard, Ulrik Lytt Rahbek, Philip Jonas Sassene, Jorrit Jeroen Water, Andreas Vegge
  • Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
    Publication number: 20210236601
    Abstract: The invention relates to pharmaceutical compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation of such compositions, and their use in medicine.
    Type: Application
    Filed: May 6, 2019
    Publication date: August 5, 2021
    Inventors: Simon Bjerregaard, Ulrik Lytt Rahbek, Philip Jonas Sassene, Jorrit Jeroen Water, Andreas Vegge